IFRXMICRO

InflaRx N.V.

HealthcareBiotechnology
$1.92
$0.00(+3.23%)
52W$0.74
$2.94
Updated Jun 28, 02:00 AM
RSI47
RS Rating93/99
Beta1.94
Volatility107%
F-Score1/9
Mkt Cap$139M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

InflaRx N.V. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings growth of 40% provides fundamental context to the price action. Investors should exercise caution due to high volatility (107% annualized), which requires wider risk management.

Relative Strength
93
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.94
vs S&P 500
HIGH BETA
52W Position
54%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.04
50 SMA > 100 SMA$1.48
100 SMA > 150 SMA$1.34
150 SMA > 200 SMA$1.35

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.87+2.65%ABOVE
50 SMA$2.04-5.75%BELOW
100 SMA$1.48+29.56%ABOVE
150 SMA$1.34+43.05%ABOVE
200 SMA$1.34+42.75%ABOVE

Price Performance

1D+3.2%
1W+1.1%
1M-29.9%
3M+110.3%
6M+74.5%
YTD+76.1%
1Y+130.6%
3Y-24.8%
52-Week Trading Range54% from low
$1.92
52W Low$0.74
52W High$2.94

Technical Indicators

RSI (14)NEUTRAL
46.8
305070
Setup ScoreCOOL
5/10
Base depth: 108.3%

Risk Profile

Beta
1.94
52W Vol
107%
ATR
$0.14
Max DD (1Y)
-53%

Volume Analysis

Today
50D Avg
1.97M
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+13%
$-0.21
Q3'25+40%
$-0.18
Q4'25-61%
$-0.14
Q1'26+40%
$-0.08
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-78.29%

Compounded Profit Growth

10 Years:-12.13%
5 Years:
3 Years:
TTM:+19.58%

Stock Price CAGR

10 Years:-18.58%
5 Years:-8.84%
3 Years:-24.83%
1 Year:+130.60%

Return on Equity

10Y Avg:-48.7%
5Y Avg:-55.4%
3Y Avg:-62.0%
Last Year:-91.1%

Key Metrics

Market Cap$139M
Gross Margin-261.1%
Net Margin-1555.8%
Piotroski F-Score1/9

Frequently Asked Questions

Is IFRX in an uptrend right now?

IFRX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is IFRX overbought or oversold?

IFRX's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is IFRX outperforming the market?

IFRX has a Relative Strength (RS) Rating of 93 out of 99. Yes, IFRX is a market leader, outperforming 93% of all stocks over the past 12 months.

Where is IFRX in its 52-week range?

IFRX is trading at $1.92, which is 65% of its 52-week high ($2.94) and 54% above its 52-week low ($0.74).

How volatile is IFRX?

IFRX has a Beta of 1.94 and 52-week volatility of 107%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.